Clinical Study

Nicotine Enemas for Active Crohn's Colitis: An Open Pilot Study

Figure 1

Outcome measures. Response of 10 patients with active Crohn’s colitis given 6 mg nicotine enemas daily for 4 weeks. Where 2 or 3 patients had the same baseline and end values, this is indicated above the connecting line, which is drawn more boldly. CDAI is Crohn’s disease activity index. Frequency is the number of stools/24 hours. Urgency of defaecation is graded: 0 = none, 1 = mild, 2 = moderate, and 3 = severe enough to cause incontinence. Sigmoidoscopic score is graded 0, normal to 4, fulminant disease. Histological scores are based on acute inflammatory activity: grade 0, no polymorphs to grade 4, florid acute inflammation with polymorphs and ulceration. Histology data is given for only 8 patients because the end-of-study biopsies of 2, both with baseline scores of 2, were insufficient for analysis.QOL is a score of quality of life as measured by the short inflammatory bowel disease questionnaire [21].Paired data were available for CRP in 7 patients and for ESR in 8 patients.
237185.fig.001a
(a)
237185.fig.001b
(b)
237185.fig.001c
(c)
237185.fig.001d
(d)
237185.fig.001e
(e)
237185.fig.001f
(f)
237185.fig.001g
(g)
237185.fig.001h
(h)